Gadoxetic acid

Key urinary metabolite of PGD2 represents approximately 1% and 4% of the infused radiolabeled dose in monkeys and humans, respectively.

Key urinary metabolite of PGD2 represents approximately 1% and 4% of the infused radiolabeled dose in monkeys and humans, respectively.

Key urinary metabolite of PGD2 represents approximately 1% and 4% of the infused radiolabeled dose in monkeys and humans, respectively.

Gadoteric acid is a macrocyclic, paramagnetic, gadolinium-based contrast agent that can be used for magnetic resonance imaging (MRI) of the brain, spine, and related tissues. In particular, Gadoteric acid is able to detect and visualize areas of

Gadoteric acid is a macrocyclic, paramagnetic, gadolinium-based contrast agent that can be used for magnetic resonance imaging (MRI) of the brain, spine, and related tissues. In particular, Gadoteric acid is able to detect and visualize areas of

Gadoteric acid is a macrocyclic, paramagnetic, gadolinium-based contrast agent that can be used for magnetic resonance imaging (MRI) of the brain, spine, and related tissues. In particular, Gadoteric acid is able to detect and visualize areas of

All-in-one ready-to-use media Quality Each lot was tested for the ability to support plating, spreading and proliferation Preparation Note contained in protocol

General description Williams&#8242: Medium E was developed by Williams and Gunn as a modification to Williams&#8242: Medium D. The medium is formulated to support long-term cell culture of adult liver epithelial cells.